IBM, Merck Declare FDA-Backed Drug Tracing Blockchain a Success

IBM, Merck, Walmart and KPMG’s drug-tracing blockchain pilot exceeded the interoperability benchmarks set by the Food and Drug Administration, the group said.

AccessTimeIconMay 4, 2020 at 8:49 p.m. UTC
Updated Aug 19, 2021 at 1:58 a.m. UTC

Presented By Icon

Election 2024 coverage presented by

Stand with crypto

IBM, Merck, Walmart and KPMG’s drug-tracing blockchain pilot has exceeded the benchmarks outlined by the U.S. Food and Drug Administration, the group announced Monday.

In their final report to the FDA, the project’s sponsor, the partners called distributed ledger technology (DLT) a safety-enhancing answer to the U.S. Drug Supply Chain Security Act (DSCSA), which gives the pharmaceutical industry until 2024 to implement stringent new electronic tracing requirements on drug packaging. 

  • Bitcoin Mining in the U.S. Will Become 'a Lot More Decentralized': Core Scientific CEO
    13:18
    Bitcoin Mining in the U.S. Will Become 'a Lot More Decentralized': Core Scientific CEO
  • Binance to Discontinue Its Nigerian Naira Services After Government Scrutiny
    05:10
    Binance to Discontinue Its Nigerian Naira Services After Government Scrutiny
  • The first video of the year 2024
    04:07
    The first video of the year 2024
  • The last regression video of the year 3.67.0
    40:07
    The last regression video of the year 3.67.0
  • “With the use of a blockchain-enabled solution, this technology might be able to address the foundational requirement of track and trace for DSCSA in addition to establishing trust between trading partners,” the report said.

    The trial began in June 2019 and the project was built on Hyperledger Fabric. At the time, a Walmart spokesperson said the company was hoping to build a more transparent supply chain for its customers.

    The companies completed the trial last December.

    "The pharma supply chain is really incredibly complex, given the number of entities and logistics providers and distributors," said Tegan Keele, KPMG's blockchain lead. All these players use different systems – oftentimes, these systems fail to meet DSCSA's interoperability requirements. The consortium's hypothesis was that blockchain could be their information bridge, she said.

    Nearly a year after testing began, the consortium found its hypothesis correct. The partners said a permissioned blockchain network could bring that highly fragmented supply chain into DSCSA compliance. The system could track drug movements while also limiting the flow of private information and, most critically, work across partners that don’t otherwise interact.

    Blockchain could also boost product safety by speeding the execution of crucial supply chain safeguards such as recalls, the group said. They estimated their blockchain could alert downstream partners of recalls in 10 seconds, an “exponentially expedited” improvement over the current pace of up to three days. 

    “To foster industry adoption, an egalitarian, inclusive, open-sourced commercial solution should be considered to help launch a blockchain network intended for information exchange of the pharmaceutical product transactions in the United States,” the group wrote in its report.

    Twenty pilots in total are participating in the FDA’s DSCSA program, and many feature blockchain and DLT. The FDA is expected to release a comprehensive final report at the conclusion of all the trials.

    Disclosure

    Please note that our privacy policy, terms of use, cookies, and do not sell my personal information have been updated.

    CoinDesk is an award-winning media outlet that covers the cryptocurrency industry. Its journalists abide by a strict set of editorial policies. CoinDesk has adopted a set of principles aimed at ensuring the integrity, editorial independence and freedom from bias of its publications. CoinDesk is part of the Bullish group, which owns and invests in digital asset businesses and digital assets. CoinDesk employees, including journalists, may receive Bullish group equity-based compensation. Bullish was incubated by technology investor Block.one.


    Learn more about Consensus 2024, CoinDesk's longest-running and most influential event that brings together all sides of crypto, blockchain and Web3. Head to consensus.coindesk.com to register and buy your pass now.